STS二尖瓣修复/置换联合冠状动脉旁路移植术复合评分
STS质量测量工作组基于2011年7月至2014年6月STS成人心脏外科数据库26463例二尖瓣修复/置换联合CABG患者,开发了包含风险调整死亡率和重大并发症复合终点的复合绩效评分。排除后24740例、703个中心参与,2%为1星(低于预期)、95%为2星(符合预期)、3%为3星(高于预期),未调整手术死亡率为6.2%,星级越高死亡率和并发症率越低。
要点
- STS发布MVRR+CABG复合绩效评分,涵盖风险调整死亡率和重大并发症。
- 703个中心中2%为1星、95%为2星、3%为3星,未调整死亡率为6.2%。
- 评分随星级升高死亡率和并发症率单调下降,可用于质量评估与患者咨询。
核心结论
- 建立了MVRR+CABG的STS复合绩效测量工具,可用于结局评估、质量改进、患者咨询、临床研究和公开报告。
研究设计与样本
- 回顾性分析STS成人心脏外科数据库2011年7月1日至2014年6月30日26463例MVRR+CABG患者,排除3年内合格病例少于10例的中心后,共24740例、703个中心纳入分析。
主要发现
- 703个中心中2%(14/703)为1星(低于预期)、95%(666/703)为2星(符合预期)、3%(23/703)为3星(高于预期)。
- 未调整手术死亡率为6.2%(1532/24740)。
- 随着星级评分升高,死亡率和并发症率呈单调下降。
关键数值与推荐
- 复合评分包含两个域:风险调整死亡率和重大并发症的任何或无发生(延长通气、深部胸骨感染、永久性卒中、肾功能衰竭和再手术)。
- 采用分层回归模型计算复合绩效评分,并使用95%贝叶斯可信区间确定高绩效和低绩效离群中心。
临床怎么用
- 该复合评分可用于MVRR+CABG的结局评估、质量改进、患者咨询、临床研究和公开报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Society of Thoracic Surgeons (STS) Quality Measurement Task Force has developed a composite performance measure for mitral repair/replacement (MVRR) with concomitant coronary artery bypass grafting (CABG). METHODS: Data were acquired from the STS Adult Cardiac Surgery Database for 26,463 patients undergoing MVRR + CABG operations between July 1, 2011, and June 30, 2014. Established STS risk models were applied, along with modifications enabling the inclusion of patients with concomitant closures of atrial septal defects and patent foramen ovale, surgical ablation for atrial fibrillation, and tricuspid valve repair (TVR). Participants with fewer than 10 eligible cases over 3 years were excluded. The MVRR + CABG composite consisted of two domains: risk-adjusted mortality and the any-or-none occurrence of major morbidity (prolonged ventilation, deep sternal infection, permanent stroke, renal failure, and reoperation). Composite performance scores were calculated with the use of hierarchic regression models, and high-performing and low-performing outliers were determined with the use of 95% Bayesian credible intervals. RESULTS: There were 24,740 patients at 703 participant sites after exclusions. Two percent (14/703) of programs were classified as 1-star (lower than expected performance), 95% (666/703) were classified as 2-star (as-expected performance), and 3% (23/703) were classified as 3-star (higher than expected performance). The average unadjusted operative mortality was 6.2% (1,532/24,740), and a monotonic decline in both mortality and morbidity was observed as star rating scores increased. CONCLUSIONS: An STS composite performance measure was developed for MVRR + CABG operations. This measure may be useful for outcome assessment, quality improvement, patient counseling, clinical research, and public reporting.
引用
- Rankin JS, Badhwar V, He X, et al. The Society of Thoracic Surgeons Mitral Valve Repair/Replacement Plus Coronary Artery Bypass Grafting Composite Score: A Report of The Society of Thoracic Surgeons Quality Measurement Task Force. Ann Thorac Surg. 2016. PMID: 27938886. doi:10.1016/j.athoracsur.2016.09.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。